Grünenthal Group-preview

Grunenthal

Grünenthal Group

Private

AachenN/Ahttps://www.grunenthal.com/

Last Round

Debt

11/14/2025

Total Funding Raised

$1.7B

Company Overview

Grünenthal Group is a pharmaceutical company that develops and commercializes treatments and technologies for pain management and related diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Grünenthal Group Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Grünenthal Group Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	11/14/2025
Debt	11/27/2024
Debt	4/25/2023
Debt	2/12/2021

View all Funding Rounds

Key People

Founding team and executive leadership

elfriede ventker

CEO

Executive Team

Gabriel Baertschi

Chairman Of The Corporate Executive Board And Chief Executive Officer

Executive Team

Anne Großkopff

CFO Forschung & Entwicklung

Executive Team

Christopher Knippen

Change & Communication Lead CFO Area

Executive Team

View all key people

Grünenthal Group Investors

Notable investors and investment history

Investor	Rounds
ING Bank	Debt
Mitsubishi UFJ Financial Group	Debt
Helaba	Debt
Mizuho Financial Group Inc.	Debt
The Goldman Sachs Group, Inc.	Debt
RBC Capital Markets	Debt
Deutsche Bank	Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 14, 2025
$202M debt round completed.
Nov 13, 2025
Monthly visitors grew 33% MoM, reaching 44.7K.

View all signals

Grünenthal Group Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Grünenthal Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Grünenthal Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersAachen

Employee Range4,628

Year Founded1946

Last Funding11/14/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.